GB Sciences, Inc. (GBLX)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
GB Sciences Revenue
GB Sciences had revenue of $97.24K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $97.24K.
Revenue (ttm)
97.24K
Revenue Growth
n/a
P/S Ratio
1.63
Revenue / Employee
48.62K
Employees
2
Market Cap
158.82K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lipella Pharmaceuticals | 389.78K |
| Endonovo Therapeutics | 255.72K |
| Scorpius Holdings | 1.72M |
| Regen BioPharma | 236.56K |
| Helix BioMedix | 2.07M |
| Affymax | 42.00K |
GB Sciences News
- 3 years ago - Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform - GlobeNewsWire
- 3 years ago - Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit - GlobeNewsWire
- 3 years ago - Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference - GlobeNewsWire
- 3 years ago - Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease - GlobeNewsWire
- 3 years ago - TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article - GlobeNewsWire